9-Valent human papillomavirus vaccine: a review of the clinical development program
A Luxembourg, E Moeller - Expert review of vaccines, 2017 - Taylor & Francis
… 9-valent human papillomavirus (9vHPV) vaccine covers the same HPV types (6/11/16/18) as
the quadrivalent HPV … of the quadrivalent and 9-valent HPV vaccine covers approximately 2 …
the quadrivalent HPV … of the quadrivalent and 9-valent HPV vaccine covers approximately 2 …
Update on the new 9-valent vaccine for human papillomavirus prevention
DY Yang, K Bracken - Canadian Family Physician, 2016 - cfp.ca
… Conclusion The 9-valent HPV vaccine offers more protection against HPV than the … new
9-valent human papillomavirus (HPV) vaccine (which includes 5 additional strains [HPV types 31…
9-valent human papillomavirus (HPV) vaccine (which includes 5 additional strains [HPV types 31…
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
WK Huh, EA Joura, AR Giuliano, OE Iversen… - The Lancet, 2017 - thelancet.com
… the nine-valent human papillomavirus (9vHPV; HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58)
vaccine against infections and disease related to HPV 31, 33, 45, 52, and 58, and non-inferior …
vaccine against infections and disease related to HPV 31, 33, 45, 52, and 58, and non-inferior …
Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence
C Signorelli, A Odone, V Ciorba, P Cella… - Epidemiology & …, 2017 - cambridge.org
… An open-label, randomized study of a 9-valent human papillomavirus vaccine given concomitantly …
of a 9-valent human papillomavirus vaccine with meningococcal and Tdap vaccines. …
of a 9-valent human papillomavirus vaccine with meningococcal and Tdap vaccines. …
[HTML][HTML] Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
… human papillomavirus (HPV) vaccination programs are established to be cost-effective before
implementation. WHO recommends HPV vaccination for girls aged 9… 9-valent HPV vaccine …
implementation. WHO recommends HPV vaccination for girls aged 9… 9-valent HPV vaccine …
[HTML][HTML] Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices
E Petrosky, JA Bocchini Jr, S Hariri, H Chesson… - MMWR Morb Mortal …, 2015 - cdc.gov
… vaccine (Adacel, Tdap) was evaluated. The GMTs were noninferior for all nine HPV vaccine
… A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J …
… A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J …
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label …
EA Joura, A Ulied, C Vandermeulen, MR Figueroa… - Vaccine, 2021 - Elsevier
… Efficacy of the nine-valent human papillomavirus (9vHPV; HPV types 6/11/16/18/31/33/45/52/58)
vaccine was demonstrated in a phase 3 study in women 16–26 years of age. We …
vaccine was demonstrated in a phase 3 study in women 16–26 years of age. We …
[HTML][HTML] Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
B Serrano, L Alemany, S Tous, L Bruni… - Infectious agents and …, 2012 - Springer
… Information on human papillomavirus (HPV) type distribution is necessary to evaluate the …
the RC of the 9 HPV types included in the V503 Merck's investigational HPV vaccine, we used …
the RC of the 9 HPV types included in the V503 Merck's investigational HPV vaccine, we used …
[HTML][HTML] From the monovalent to the nine-valent HPV vaccine
S Pils, EA Joura - Clinical Microbiology and Infection, 2015 - Elsevier
… An investigational monovalent human papillomavirus (HPV) 16 virus-like particle vaccine
has been shown to prevent persistent infection and cervical disease related to …
has been shown to prevent persistent infection and cervical disease related to …
Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination
SS Ng, R Hutubessy, N Chaiyakunapruk - Vaccine, 2018 - Elsevier
… optimizing the uptake of HPV vaccine. Given the increasing … HPV vaccination, by focusing
on: (i) 9-valent vaccine compared to bi- or quadrivalent vaccine; (ii) gender-neutral vaccination …
on: (i) 9-valent vaccine compared to bi- or quadrivalent vaccine; (ii) gender-neutral vaccination …
相关搜索
- 9 valent human papillomavirus immunization practices
- 9 valent human papillomavirus cost effectiveness
- quadrivalent human papillomavirus vaccine
- interim analysis human papillomavirus vaccine
- human papillomavirus vaccines systematic review
- human papillomavirus vaccine delivery
- economic evaluation of human papillomavirus vaccination
- human papillomavirus vaccination programme
- clinical trials of human papillomavirus vaccines
- clinical development program human papillomavirus vaccine
- final efficacy human papillomavirus vaccine
- 2 dose schedule human papillomavirus vaccination
- latin american girls human papillomavirus vaccine
- chinese females human papillomavirus vaccine
- safety profile human papillomavirus vaccine
- asian countries human papillomavirus vaccine